US EditionPublished • loading... • Updated
Caris Signs Genentech Deal Worth up to $1.1 Billion for Rare ...
Summary by PR Newswire
9 Articles
9 Articles
Farm Talk Newspaper+6 Reposted by 6 other sources
Caris Life Sciences Announces Collaboration with Genentech to Discover Novel Therapeutic Targets in Cancers with High Unmet Clinical Need
IRVING, Texas, Dec. 16, 2025 /PRNewswire/ -- Caris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, today announced that its therapeutic research arm, Caris Discovery, has entered into a multi-year collaboration and license…
·Parsons, United States
Read Full Article
Coverage Details
Total News Sources9
Leaning Left1Leaning Right0Center4Last UpdatedBias Distribution80% Center
Bias Distribution
- 80% of the sources are Center
80% Center
L 20%
C 80%
Factuality
To view factuality data please Upgrade to Premium
